This content is not available due to your privacy preferences.Update your settings here to see it.
  • Reuters

    SentinelOne's disappointing forecast slams shares

    The stock could erase most of the 42% rise it has posted so far this year, if losses hold through regular trading. More than half of the 30 analysts covering the stock lowered their target prices, citing the longer deal cycles and waning demand from enterprise customers, who are holding back on new orders due to high inflation and rising interest rates. The median price target on the stock is now $18, which is 13% lower than its last closing price.

  • Yahoo Finance

    Jobs report: US economy adds 339,000 jobs in May, crushing expectations

    The May jobs report will be closely analyzed by investors looking for hints on what the Fed will do at its June meeting.

  • Motley Fool

    3 High-Quality Dividend Stocks Yielding 3% to Buy in June

    Many high-quality dividend stocks currently yield around 3%, nearly double that of the S&P 500. American Tower's dividend yield is currently over 3%, a historically high rate for the data-infrastructure real estate investment trust (REIT). The company has an exceptional track record of paying dividends.

  • Engadget

    Engadget Podcast: Apple WWDC 2023 preview

    We explore why Apple may want to dive into mixed reality.

  • Motley Fool

    This Is Why Your Credit Card Debt Could Get More Expensive Soon

    Do you have credit card debt? Credit card interest rates could rise soon, making your debt more costly. Find out how this news could impact your finances.

  • Motley Fool

    7 Things You Should Never (Ever) Do at Costco

    Even a Costco expert can learn a trick or two. That includes these seven things you should never do at Costco.

  • PR Newswire

    Nisun International Regains Compliance with NASDAQ Minimum Bid Price Requirement

    Nisun International Enterprise Development Group Co., Ltd (Nasdaq: NISN) ("Nisun" or the "Company") announced today that it has received a Staff determination letter (the "Letter") from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("NASDAQ") dated May 26, 2023 notifying the Company of the Staff's determination to delist the Company's securities from The Nasdaq Capital Market because the Company had failed to satisfy the requirement that the closing bid price of its securi

  • GlobeNewswire

    Dolby Laboratories President and CEO Kevin Yeaman to Host Fireside Chat at the William Blair Growth Stock Conference

    SAN FRANCISCO, June 02, 2023 (GLOBE NEWSWIRE) -- Dolby Laboratories, Inc. (NYSE:DLB) today announced that Kevin Yeaman, President and CEO, will host a fireside chat at the 43rd Annual William Blair Growth Stock Conference in Chicago, Illinois, on Tuesday, June 6, 2023, at 10:00 a.m. CT (8:00 a.m. PT). A live webcast and replay of the event will be available at About Dolby Laboratories Dolby Laboratories (NYSE: DLB) is based in San Francisco, California with offices aro

  • PR Newswire

    ThinkCERCA Launches Benchmark Evaluation Service

    ThinkCERCA, a recognized industry leader in student reading and writing growth, has expanded its product offerings to include a start-to-finish benchmark assessment and evaluation service. This includes the administration of the assessments, the evaluation by professional scorers, and comprehensive feedback and data reporting.

  • GlobeNewswire

    Alpha Sigma Capital Initiates Research Coverage on Syntropy (NOIA)

    Syntropy (NOIA) is an open project providing next-generation connectivity technology for the Internet.Bradenton, FL, June 02, 2023 (GLOBE NEWSWIRE) -- Alpha Sigma Capital Research, a leading blockchain research enterprise, provided by Alpha Transform Holdings, initiated research coverage on Syntropy Highlights include:1. Launched Distributed Autonomous Routing Protocol2. FIFA Launch success3. Launched Public Chain4. Advanced development of beta for web3 decentralized development underway5. Secur

  • PR Newswire

    Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestones

    Terran Biosciences, Inc. ("Terran"), a CNS-focused biotech platform company, has entered into an agreement with French pharmaceutical company Pierre Fabre Médicament S.A.S ("Pierre Fabre") for worldwide exclusive rights to develop and commercialize a pipeline of Pierre Fabre's assets to treat neuropsychiatric illnesses.

  • GlobeNewswire

    eXp Realty Unites With Vesta Settlements to Provide Local Title Services in Virginia

    Brokerage to launch additional title service ventures across United States eXp Realty Unites With Vesta Settlements to Provide Local Title Services in Virginia eXp Realty Brokerage to launch additional title service ventures across United States BELLINGHAM, Wash., June 02, 2023 (GLOBE NEWSWIRE) -- eXp Realty®, “the most agent-centric real estate brokerage on the planet™” and the core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), today announced a strategic title and brokerage joint vent

  • GlobeNewswire

    Next-generation Sequencing (NGS) Market is Expected to Reach $27.0 billion | MarketsandMarkets.

    Chicago, June 02, 2023 (GLOBE NEWSWIRE) -- The next-generation sequencing (NGS) industry is poised for remarkable growth and innovation in the near future. NGS has revolutionized genomics research and clinical applications by enabling rapid and cost-effective sequencing of DNA and RNA, providing unprecedented insights into genetic variation, disease mechanisms, and personalized medicine. With continuous advancements in sequencing technologies, we can expect NGS to become even more powerful, effi

  • Business Wire

    Columbus McKinnon to Webcast Fireside Chat at the Wells Fargo Industrials Conference

    BUFFALO, N.Y., June 02, 2023--Columbus McKinnon (Nasdaq: CMCO) to Webcast Fireside Chat at the Wells Fargo Industrials Conference

  • GlobeNewswire

    22nd Century Group (XXII) Announces Participation in the LD Micro Invitational XIII

    BUFFALO, N.Y., June 02, 2023 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (Nasdaq: XXII), a leading biotechnology company dedicated to improving health with reduced nicotine tobacco, hemp/cannabis and hops advanced plant technologies, today announced it will participate in the 13th Annual LD Micro Invitational at the Luxe Sunset Boulevard Hotel, Los Angeles, California on June 6th-8th, 2023. The event is expected to feature 150+ companies, presenting in half-hour increments, as well as private o

  • PR Newswire

    Akebia Therapeutics to Present at Jefferies Healthcare Conference

    Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that John Butler, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Wednesday, June 7, 2023 at 8:30 a.m. ET. In his presentation, Mr. Butler will discuss recent regulatory updates regarding vadadustat, Akebia's oral hypoxia-inducible factor prolyl hydroxylase inhibitor for the treatment of anemia due to chro

  • Business Wire

    Ciena to Webcast Financial Community Event

    HANOVER, Md., June 02, 2023--June 2, 2023 Ciena® Corporation today announced its expected participation in the following upcoming event with the financial community.

  • GlobeNewswire

    Hyperthermia Cancer Treatment Market to Grow 5.9% CAGR, Worth US$ 266 Million by 2030 | TMR Study

    Companies in the hyperthermia cancer treatment market are considered to be boosting due to the help of deep tissue thermal therapy attributed to the non-protruding nature that still prohibits the need for anesthesia. North America is estimated to provide a significant share of the hyperthermia cancer treatment market opportunities to regional and global manufacturers.Wilmington, Delaware, United States, June 02, 2023 (GLOBE NEWSWIRE) -- The global hyperthermia cancer treatment market stood at US

  • GlobeNewswire

    Bon Natural Life Limited Launches Three New Cruciferous Vegetable-Based Powder Drinks

    XI'AN, China, June 02, 2023 (GLOBE NEWSWIRE) -- Bon Natural Life Limited (Nasdaq: BON) ("BON" or the "Company"), one of the leading bio-ingredient solutions providers in the natural, health and personal care industries, today announced the launch of three powder drinks to its cruciferous vegetable-based health supplement series. The new powder drinks include: broccoli seed caffeine powder drink, broccoli seed coconut powder drink, and broccoli seed green tea powder drink. Thoughtfully formulated

  • PR Newswire

    Neurocrine Biosciences Presents INGREZZA® (valbenazine) Capsules Data on Tardive Dyskinesia Improvement Regardless of Baseline Antipsychotic Use at 2023 Psych Congress Elevate

    Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today presented findings from a meta-analysis of three long-term studies evaluating INGREZZA® (valbenazine) capsules that demonstrated substantial and sustained improvements in tardive dyskinesia (TD) in adults with or without concomitant antipsychotic therapy. The data (Poster #4) were presented at 2023 Psych Congress Elevate in Las Vegas.

  • Business Wire

    DatChat, Inc. Provides Update on Share Repurchase Program

    NEW BRUNSWICK, N.J., June 02, 2023--DatChat, Inc. ("DatChat" or the "Company") (Nasdaq: DATS), today provided an update on the $2 million share repurchase program (the "Share Repurchase Program") authorized by the Company's Board of Directors on January 6, 2023.

  • Business Wire

    Ecolomondo Releases Its Interim Consolidated Financial Statements for the First Quarter of 2023

    MONTREAL, June 02, 2023--Ecolomondo Corporation (TSXV: ECM) (OTC: ECLMF) (the "Company" or "Ecolomondo"), a cleantech company specializing in the commercialization of its Thermal Decomposition Process ("TDP") proprietary recycling technology and the global deployment of TDP turnkey facilities, announces that it has released its unaudited consolidated financial statements and notes thereto and its related management discussion and analysis for the interim period ended March 31, 2023 (the "Interim

  • Business Wire

    RXO Announces Participation at Wells Fargo Industrials Conference

    CHARLOTTE, N.C., June 02, 2023--RXO (NYSE: RXO) today announced that Drew Wilkerson, chief executive officer, and Kevin Sterling, senior market strategist, will participate in the Wells Fargo Industrials Conference in Chicago, Illinois, on Wednesday, June 14, from 3:10 p.m. until 3:45 p.m. EDT.

  • Business Wire

    Director/PDMR Shareholding

    LONDON, June 02, 2023-- 2 June 2023

  • GlobeNewswire

    Bronek Masojada appointed Chair of SiriusPoint

    HAMILTON, Bermuda, June 02, 2023 (GLOBE NEWSWIRE) -- SiriusPoint Ltd. (“SiriusPoint” or the “Company”) (NYSE:SPNT), a global specialty insurer and reinsurer, has announced the appointment of Bronek Masojada as Chair of the Company’s Board of Directors, effective immediately. Mr Masojada, who joined the board on May 2 this year, is an insurance market veteran with over 30 years’ leadership experience in the industry. Sharon Ludlow, who joined the board in February 2021 and has been interim Chair